The role of miR-210, E2F3 and ephrin A3 in angiosarcoma cell proliferation
- PMID: 28739548
- DOI: 10.1684/ejd.2017.3084
The role of miR-210, E2F3 and ephrin A3 in angiosarcoma cell proliferation
Abstract
Background: Although angiosarcoma exhibits aggressive progression and is associated with unfavourable prognosis, its pathogenesis is poorly understood.
Objectives: In the present study, we investigated the possibility that microRNAs play a role in the pathogenesis of angiosarcoma.
Materials & methods: microRNA expression was evaluated by array analysis and real-time PCR, and protein expression was determined by immunohistochemistry and immunoblotting.
Results: miR-210 expression was decreased in angiosarcoma cells both in vivo and in vitro. E2F3 and ephrin A3 are putative targets of miR-210, and their protein expression was up-regulated in the tumour cells. Knockdown of E2F3 or ephrin A3 resulted in a significant decrease in the number of angiosarcoma cells.
Conclusion: Further investigations into the regulatory mechanisms of oncogenesis associated with miR-210/E2F3/ephrin A3 signalling may lead to a new therapeutic approach against angiosarcoma.
Keywords: E2F3; angiosarcoma; ephrin A3; miR-210; microRNA; proliferation.
Similar articles
-
miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma.Oncotarget. 2016 Sep 6;7(36):58148-58161. doi: 10.18632/oncotarget.11252. Oncotarget. 2016. PMID: 27531900 Free PMC article.
-
MiR-210 knockdown promotes the development of pancreatic cancer via upregulating E2F3 expression.Eur Rev Med Pharmacol Sci. 2018 Dec;22(24):8640-8648. doi: 10.26355/eurrev_201812_16628. Eur Rev Med Pharmacol Sci. 2018. PMID: 30575904
-
MiR-141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down-Regulating E2F3 Expression.Dig Dis Sci. 2015 Nov;60(11):3271-82. doi: 10.1007/s10620-015-3782-x. Epub 2015 Aug 2. Dig Dis Sci. 2015. PMID: 26233544
-
MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma.Mol Cancer. 2015 Mar 26;14:68. doi: 10.1186/s12943-015-0338-9. Mol Cancer. 2015. PMID: 25889255 Free PMC article.
-
MicroRNA-340 inhibits the growth and invasion of angiosarcoma cells by targeting SIRT7.Biomed Pharmacother. 2018 Jul;103:1061-1068. doi: 10.1016/j.biopha.2018.04.148. Epub 2018 Apr 25. Biomed Pharmacother. 2018. PMID: 29710664
Cited by
-
MicroRNAs in the Pathogenesis, Prognostication and Prediction of Treatment Resistance in Soft Tissue Sarcomas.Cancers (Basel). 2023 Jan 18;15(3):577. doi: 10.3390/cancers15030577. Cancers (Basel). 2023. PMID: 36765536 Free PMC article. Review.
-
Association between microRNA 671 polymorphisms and the susceptibility to soft tissue sarcomas in a Chinese population.Front Oncol. 2022 Aug 9;12:960269. doi: 10.3389/fonc.2022.960269. eCollection 2022. Front Oncol. 2022. PMID: 36016604 Free PMC article.
-
Increased Expression of Ephrins on Immune Cells of Patients with Relapsing Remitting Multiple Sclerosis Affects Oligodendrocyte Differentiation.Int J Mol Sci. 2021 Feb 22;22(4):2182. doi: 10.3390/ijms22042182. Int J Mol Sci. 2021. PMID: 33671716 Free PMC article.
-
MST4 Regulates Epithelial-Mesenchymal Transition of Choriocarcinoma by Mediating TGF-β1 Expression.Onco Targets Ther. 2020 Nov 19;13:11935-11946. doi: 10.2147/OTT.S269168. eCollection 2020. Onco Targets Ther. 2020. PMID: 33244239 Free PMC article.
-
A potential significance of circ_0024169 down regulation in angiosarcoma tissue.Intractable Rare Dis Res. 2019 May;8(2):129-133. doi: 10.5582/irdr.2019.01034. Intractable Rare Dis Res. 2019. PMID: 31218163 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
